Copyright Reports & Markets. All rights reserved.

Global Atropine Sulfate Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Atropine Sulfate Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 0.5 mg/mL
    • 1.3.3 1 mg/ml
    • 1.3.4 5 mg/ml
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Atropine Sulfate Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Atropine Sulfate Injection Market Size & Forecast
    • 1.5.1 Global Atropine Sulfate Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Atropine Sulfate Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Atropine Sulfate Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Atropine Sulfate Injection Product and Services
    • 2.1.4 Pfizer Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 American Regent
    • 2.2.1 American Regent Details
    • 2.2.2 American Regent Major Business
    • 2.2.3 American Regent Atropine Sulfate Injection Product and Services
    • 2.2.4 American Regent Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 American Regent Recent Developments/Updates
  • 2.3 Hikma Pharmaceuticals
    • 2.3.1 Hikma Pharmaceuticals Details
    • 2.3.2 Hikma Pharmaceuticals Major Business
    • 2.3.3 Hikma Pharmaceuticals Atropine Sulfate Injection Product and Services
    • 2.3.4 Hikma Pharmaceuticals Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Hikma Pharmaceuticals Recent Developments/Updates
  • 2.4 Apotex
    • 2.4.1 Apotex Details
    • 2.4.2 Apotex Major Business
    • 2.4.3 Apotex Atropine Sulfate Injection Product and Services
    • 2.4.4 Apotex Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Apotex Recent Developments/Updates
  • 2.5 Amneal Pharmaceuticals
    • 2.5.1 Amneal Pharmaceuticals Details
    • 2.5.2 Amneal Pharmaceuticals Major Business
    • 2.5.3 Amneal Pharmaceuticals Atropine Sulfate Injection Product and Services
    • 2.5.4 Amneal Pharmaceuticals Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Amneal Pharmaceuticals Recent Developments/Updates
  • 2.6 Accord Healthcare
    • 2.6.1 Accord Healthcare Details
    • 2.6.2 Accord Healthcare Major Business
    • 2.6.3 Accord Healthcare Atropine Sulfate Injection Product and Services
    • 2.6.4 Accord Healthcare Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Accord Healthcare Recent Developments/Updates
  • 2.7 China Res Double-Crane
    • 2.7.1 China Res Double-Crane Details
    • 2.7.2 China Res Double-Crane Major Business
    • 2.7.3 China Res Double-Crane Atropine Sulfate Injection Product and Services
    • 2.7.4 China Res Double-Crane Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 China Res Double-Crane Recent Developments/Updates
  • 2.8 Hebei Kaiwei Pharmaceutical
    • 2.8.1 Hebei Kaiwei Pharmaceutical Details
    • 2.8.2 Hebei Kaiwei Pharmaceutical Major Business
    • 2.8.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.8.4 Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hebei Kaiwei Pharmaceutical Recent Developments/Updates
  • 2.9 Hebei Tiancheng Pharmaceutical
    • 2.9.1 Hebei Tiancheng Pharmaceutical Details
    • 2.9.2 Hebei Tiancheng Pharmaceutical Major Business
    • 2.9.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.9.4 Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
  • 2.10 Tai Yu Chemical & Pharmaceutical
    • 2.10.1 Tai Yu Chemical & Pharmaceutical Details
    • 2.10.2 Tai Yu Chemical & Pharmaceutical Major Business
    • 2.10.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.10.4 Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
  • 2.11 Tianjin Jinyao Pharmaceutical
    • 2.11.1 Tianjin Jinyao Pharmaceutical Details
    • 2.11.2 Tianjin Jinyao Pharmaceutical Major Business
    • 2.11.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.11.4 Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Tianjin Jinyao Pharmaceutical Recent Developments/Updates
  • 2.12 Sunflower Pharmaceutical
    • 2.12.1 Sunflower Pharmaceutical Details
    • 2.12.2 Sunflower Pharmaceutical Major Business
    • 2.12.3 Sunflower Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.12.4 Sunflower Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Sunflower Pharmaceutical Recent Developments/Updates
  • 2.13 China Shineway Pharm
    • 2.13.1 China Shineway Pharm Details
    • 2.13.2 China Shineway Pharm Major Business
    • 2.13.3 China Shineway Pharm Atropine Sulfate Injection Product and Services
    • 2.13.4 China Shineway Pharm Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 China Shineway Pharm Recent Developments/Updates
  • 2.14 CSPC Ouyi Pharmaceutical
    • 2.14.1 CSPC Ouyi Pharmaceutical Details
    • 2.14.2 CSPC Ouyi Pharmaceutical Major Business
    • 2.14.3 CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.14.4 CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
  • 2.15 Suicheng Pharmaceutical
    • 2.15.1 Suicheng Pharmaceutical Details
    • 2.15.2 Suicheng Pharmaceutical Major Business
    • 2.15.3 Suicheng Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.15.4 Suicheng Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Suicheng Pharmaceutical Recent Developments/Updates
  • 2.16 Chengdu Brilliant Pharmaceutical
    • 2.16.1 Chengdu Brilliant Pharmaceutical Details
    • 2.16.2 Chengdu Brilliant Pharmaceutical Major Business
    • 2.16.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.16.4 Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
  • 2.17 Anhui Changjiang Pharmaceutical
    • 2.17.1 Anhui Changjiang Pharmaceutical Details
    • 2.17.2 Anhui Changjiang Pharmaceutical Major Business
    • 2.17.3 Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.17.4 Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Anhui Changjiang Pharmaceutical Recent Developments/Updates
  • 2.18 Shanghai Harvest Pharmaceutical
    • 2.18.1 Shanghai Harvest Pharmaceutical Details
    • 2.18.2 Shanghai Harvest Pharmaceutical Major Business
    • 2.18.3 Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.18.4 Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
  • 2.19 Hubei Xinghua Pharmaceutical
    • 2.19.1 Hubei Xinghua Pharmaceutical Details
    • 2.19.2 Hubei Xinghua Pharmaceutical Major Business
    • 2.19.3 Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Product and Services
    • 2.19.4 Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Hubei Xinghua Pharmaceutical Recent Developments/Updates
  • 2.20 Changzhou Pharmaceutical Factory
    • 2.20.1 Changzhou Pharmaceutical Factory Details
    • 2.20.2 Changzhou Pharmaceutical Factory Major Business
    • 2.20.3 Changzhou Pharmaceutical Factory Atropine Sulfate Injection Product and Services
    • 2.20.4 Changzhou Pharmaceutical Factory Atropine Sulfate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Changzhou Pharmaceutical Factory Recent Developments/Updates

3 Competitive Environment: Atropine Sulfate Injection by Manufacturer

  • 3.1 Global Atropine Sulfate Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Atropine Sulfate Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Atropine Sulfate Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Atropine Sulfate Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Atropine Sulfate Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Atropine Sulfate Injection Manufacturer Market Share in 2025
  • 3.5 Atropine Sulfate Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Atropine Sulfate Injection Market: Region Footprint
    • 3.5.2 Atropine Sulfate Injection Market: Company Product Type Footprint
    • 3.5.3 Atropine Sulfate Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Atropine Sulfate Injection Market Size by Region
    • 4.1.1 Global Atropine Sulfate Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Atropine Sulfate Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Atropine Sulfate Injection Average Price by Region (2021-2032)
  • 4.2 North America Atropine Sulfate Injection Consumption Value (2021-2032)
  • 4.3 Europe Atropine Sulfate Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Atropine Sulfate Injection Consumption Value (2021-2032)
  • 4.5 South America Atropine Sulfate Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Atropine Sulfate Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Atropine Sulfate Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Atropine Sulfate Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Atropine Sulfate Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Atropine Sulfate Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Atropine Sulfate Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Atropine Sulfate Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Atropine Sulfate Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Atropine Sulfate Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Atropine Sulfate Injection Market Size by Country
    • 7.3.1 North America Atropine Sulfate Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Atropine Sulfate Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Atropine Sulfate Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Atropine Sulfate Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Atropine Sulfate Injection Market Size by Country
    • 8.3.1 Europe Atropine Sulfate Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Atropine Sulfate Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Atropine Sulfate Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Atropine Sulfate Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Atropine Sulfate Injection Market Size by Region
    • 9.3.1 Asia-Pacific Atropine Sulfate Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Atropine Sulfate Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Atropine Sulfate Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Atropine Sulfate Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Atropine Sulfate Injection Market Size by Country
    • 10.3.1 South America Atropine Sulfate Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Atropine Sulfate Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Atropine Sulfate Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Atropine Sulfate Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Atropine Sulfate Injection Market Size by Country
    • 11.3.1 Middle East & Africa Atropine Sulfate Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Atropine Sulfate Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Atropine Sulfate Injection Market Drivers
  • 12.2 Atropine Sulfate Injection Market Restraints
  • 12.3 Atropine Sulfate Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Atropine Sulfate Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Atropine Sulfate Injection
  • 13.3 Atropine Sulfate Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Atropine Sulfate Injection Typical Distributors
  • 14.3 Atropine Sulfate Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Atropine Sulfate Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Atropine Sulfate Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Atropine Sulfate Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Atropine Sulfate Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Atropine Sulfate Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Atropine Sulfate Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Atropine Sulfate Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Atropine Sulfate Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, American Regent, Hikma Pharmaceuticals, Apotex, Amneal Pharmaceuticals, Accord Healthcare, China Res Double-Crane, Hebei Kaiwei Pharmaceutical, Hebei Tiancheng Pharmaceutical, Tai Yu Chemical & Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Atropine Sulfate Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    0.5 mg/mL
    1 mg/ml
    5 mg/ml
    Other
    Market segment by Application
    Online Sales
    Offline Sales
    Major players covered
    Pfizer
    American Regent
    Hikma Pharmaceuticals
    Apotex
    Amneal Pharmaceuticals
    Accord Healthcare
    China Res Double-Crane
    Hebei Kaiwei Pharmaceutical
    Hebei Tiancheng Pharmaceutical
    Tai Yu Chemical & Pharmaceutical
    Tianjin Jinyao Pharmaceutical
    Sunflower Pharmaceutical
    China Shineway Pharm
    CSPC Ouyi Pharmaceutical
    Suicheng Pharmaceutical
    Chengdu Brilliant Pharmaceutical
    Anhui Changjiang Pharmaceutical
    Shanghai Harvest Pharmaceutical
    Hubei Xinghua Pharmaceutical
    Changzhou Pharmaceutical Factory
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Atropine Sulfate Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Atropine Sulfate Injection, with price, sales quantity, revenue, and global market share of Atropine Sulfate Injection from 2021 to 2026.
    Chapter 3, the Atropine Sulfate Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Atropine Sulfate Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Atropine Sulfate Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Atropine Sulfate Injection.
    Chapter 14 and 15, to describe Atropine Sulfate Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now